IntegraGen SA Establishes a US Subsidiary to Commercialize Its Molecular Tests in the USA: Robert Gottlieb Appointed CEO of IntegraGen, Inc.PARIS Paris, in Greek mythology Paris or Alexander, in Greek mythology, son of Priam and Hecuba and brother of Hector. Because it was prophesied that he would cause the destruction of Troy, Paris was abandoned on Mt. & NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- IntegraGen SA, the personalized healthcare company focused on the development and commercialization of molecular diagnostic tests for complex diseases, has announced the establishment of IntegraGen, Inc., a wholly-owned US subsidiary, based in New York. Robert Gottlieb has been appointed as its Chief Executive Officer. Commenting on the move, Mr. Gottlieb said: "It is a pleasure to join IntegraGen as the firm moves toward commercialization of its first product in the United States. The company has done an excellent job discovering and patent protecting biomarkers associated with complex diseases and leveraging the expertise of well respected partners. Based on discussions with researchers and clinicians, IntegraGen is uniquely positioned to deliver molecular diagnostic products that will improve the quality of life for millions of individuals. In addition to his role as Chief Executive Officer of IntegraGen, Inc, Mr. Gottlieb, who has been working with IntegraGen for the past five months, also holds the position of VP Global Sales and Marketing for the IntegraGen Group, where he has responsibility for sales and marketing of Diagnostic Testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease and Counselling services offered through the Company's Diabetes Competence Center, in Bonn and the Genetic Research Services business, based in France. Mr. Gottlieb has more than twenty years working experience in the Diagnostics and Medical Device Industry with firms including Abbott Laboratories, General Electric, and Becton Dickinson. Prior to IntegraGen, he was with Roche Diagnostics, where he held a variety of Director level positions. He obtained his M.B.A. from Temple University, Philadelphia, PA, a B.A. in Biology from LaSalle University, Philadelphia, PA. Dr. Jan Mous, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of IntegraGen SA, said: "With the incorporation of IntegraGen Inc., the IntegraGen Group has made a significant step forward and allows the Group to effectively market its genetic testing services into this important market." "We are very pleased to welcome Rob to the team - his expertise will be critical in helping drive our sales and marketing strategy forward." Notes to editors: About IntegraGen IntegraGen is a pioneer in the field of predictive healthcare. The company uses its unique genomic analysis expertise to identify genes associated with complex diseases and commercializes molecular diagnostic tests to enable individualized diagnosis, prevention and treatment. IntegraGen's proprietary gene mapping technology GenomeHIP[TM] provides fast, reliable, and cost-effective discovery of genetic loci. Paired with strong biostatistics, bioinformatics and fine mapping genotyping capabilities, IntegraGen has successfully identified and patented genes associated with early and late onset diseases. Efforts are currently focused on Type-2 Diabetes, Obesity, Autism autism (ô`tĭzəm), developmental disability resulting from a neurological disorder that affects the normal functioning of the brain. It is characterized by the abnormal development of communication skills, social skills, and reasoning. and Bi-Polar Disorder. Clinical trials for the company's first genetic test for autism, based on internally identified genes, are planned for Q1 2007. IntegraGen has two commercial operations. Diagnostic testing and counselling services are offered through a Diabetes Competence Center, based in Bonn, Germany. The Company has recently received accreditation under ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. Standard 17025 for performing human genetic analyses in this Centre. A Genetic Services business, operating out of the company's headquarters in Evry, France, provides customized genotyping and BAC BAC abbr. blood alcohol concentration array services to the research community. The Company also entered recently into a collaborative R&D partnership with the DSM 1. DSM - Data Structure Manager. An object-oriented language by J.E. Rumbaugh and M.E. Loomis of GE, similar to C++. It is used in implementation of CAD/CAE software. DSM is written in DSM and C and produces C as output. Personalized Nutrition Group. IntegraGen closed successfully its second financing round raising [euro]8 million ($9.6 million), in 2005. In November 2006, DSM Venturing, the corporate venturing arm of Royal DSM N.V. invested [euro]2M in the Company, bringing the total capital raised by IntegraGen to date to [euro]22 million ($28million). The international syndicate of investors included CDC See Control Data, century date change and Back Orifice. CDC - Control Data Corporation Entreprises Innovation, AGF AGF Assurances Générales de France AGF Army Ground Forces AGF American Growth Fund (mutual fund) AGF American General Finance AGF Arbeitsgemeinschaft der Grossforschungseinrichtungen AGF Anatomic Gift Foundation AGF Assume Good Faith Private Equity, Bioam, SGAM SGAM Schweizerische Gesellschaft Für Allgemeinmedizin (Swiss Association for General Medicine, aka: SSMG) Alternative Investments, Baytech Venture Capital, and Avenir Finance Gestion. Founded in July 2000, IntegraGen has 34 employees and is based in the French Genopole of Evry, near Paris, France, in Bonn, Germany and in New York, USA. More information can be found at www.integragen.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion